Scar News and Research RSS Feed - Scar News and Research

MDI Biological Laboratory researchers receive patent for novel heart disease drug

MDI Biological Laboratory researchers receive patent for novel heart disease drug

The U.S. Patent and Trademark Office has announced that it will grant a patent to MDI Biological Laboratory scientists Voot P. Yin, Ph.D., and Kevin Strange, Ph.D., and their collaborator Michael Zasloff, M.D., Ph.D., for use of the small molecule MSI-1436 to stimulate the repair and regeneration of heart tissue damaged by injuries such as a heart attack. [More]
Obstructive sleep apnea and hypoxia linked to progression of NAFLD in obese adolescents

Obstructive sleep apnea and hypoxia linked to progression of NAFLD in obese adolescents

Researchers from the University of Colorado School of Medicine have published a new study showing that sleep apnea worsens non-alcoholic fatty liver disease in obese adolescents. [More]
ISBI releases evidence-based practice guidelines to enhance and standardize burn care

ISBI releases evidence-based practice guidelines to enhance and standardize burn care

Burns can be among the most devastating of injuries. Following the formulation of practice guidelines (PGs) that addressed the care and management of burn injuries in developed countries, the International Society for Burn Injuries has updated these recommendations to guide the improvement of care of burn patients in resource-limited settings (RLS). [More]
Noninvasive approach using pulsed electric fields may reduce scarring after burn injuries

Noninvasive approach using pulsed electric fields may reduce scarring after burn injuries

A Massachusetts General Hospital research team has reported that repeated treatment with pulsed electric fields - a noninvasive procedure that does not generate heat - may help reduce the development of scarring. [More]
Researchers develop new non-invasive technique to prevent burn scars

Researchers develop new non-invasive technique to prevent burn scars

A group of researchers from Tel Aviv University and Harvard University has devised a new non-invasive method to prevent burn scarring caused by the proliferation of collagen cells. [More]
Sleep-disordered breathing promotes progression of pediatric NAFLD to NASH

Sleep-disordered breathing promotes progression of pediatric NAFLD to NASH

Studies have shown that obstructive sleep apnea and low nighttime oxygen, which result in oxidative stress, are associated with the progression of non-alcoholic fatty liver disease (NAFLD) in adults. [More]
Research shows alcohol abuse drug inhibits ocular conjunctival scarring in mouse model

Research shows alcohol abuse drug inhibits ocular conjunctival scarring in mouse model

New research from University College London, Moorfields Eye Hospital and Duke University School of Medicine has identified a gene that drives scarring, together with a rapidly translatable therapy, for the UK's most common cause of blinding conjunctivitis. [More]
Scarring can have negative impact on patients' quality of life

Scarring can have negative impact on patients' quality of life

Whether it's from sudden trauma, scheduled surgery or serious acne, scarring can have a profound impact on patients. [More]
Groundbreaking research opens door for prevention of cardiac fibrosis

Groundbreaking research opens door for prevention of cardiac fibrosis

Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis—a condition leading to heart failure for which there is currently no treatment. [More]
Scientists discover promising approach to combat life-threatening bacterial infections without antibiotics

Scientists discover promising approach to combat life-threatening bacterial infections without antibiotics

Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. [More]
Cryopreserved human umbilical cord patch shows promise in treating fetal spina bifida

Cryopreserved human umbilical cord patch shows promise in treating fetal spina bifida

A patch made from cryopreserved human umbilical cord may be a novel method for treating spina bifida in utero, according to researchers at McGovern Medical School at The University of Texas Health Science Center at Houston. [More]
FDA approves new ExAblate Neuro to treat patients with essential tremor

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors. [More]
Major trial to test new surgical approach for patients with lung cancer

Major trial to test new surgical approach for patients with lung cancer

The University of Montreal Hospital Research Centre is launching a major international clinical trial to test a minimally invasive and safer surgical approach for patients with lung cancer: video-assisted thoracoscopic (VATS) lobectomy with ultrasonic pulmonary artery sealing. [More]
New topical film patch can effectively close dermal wounds, reduce scarring

New topical film patch can effectively close dermal wounds, reduce scarring

Currently there is no product available based on polymer film containing active molecules to accelerate dermal wound healing that also reduces the scar formation. [More]
Loyola among first health systems to offer absorbable stent to heart patients

Loyola among first health systems to offer absorbable stent to heart patients

Loyola Medicine will be among the first health systems in the country to offer heart patients a new stent that is absorbed by the body once it has served its purpose. [More]
FDA approves Absorb GT1 BVS to treat coronary artery disease

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. [More]
Immunotherapy in conjunction with drugs could be effective in treating pancreatic cancer

Immunotherapy in conjunction with drugs could be effective in treating pancreatic cancer

While immune therapy has proven effective in treating certain types of cancer, especially lung cancer and melanoma, tumors of the pancreas remain among the most difficult to treat and, so far, are impervious to immune-based therapies. [More]
Re-engineering cardiac scarring process could improve clinical outcomes for heart disease patients

Re-engineering cardiac scarring process could improve clinical outcomes for heart disease patients

Literal heartbreak, from illness or injury, triggers the body's natural healing mechanisms. [More]
Study evaluates effectiveness of robotic approach over manual ablation in treating heart arrhythmia

Study evaluates effectiveness of robotic approach over manual ablation in treating heart arrhythmia

Whether ablation of the highest-risk heart arrhythmia is best handled by a robot or the hands of an electrophysiologist should be answered by an international comparison of the two. [More]
Portal vein hypertension diminishes after hepatitis C recovery

Portal vein hypertension diminishes after hepatitis C recovery

This inflammatory viral infection of the liver causes inflexible scar tissue to form. This in turn impedes blood flow through the organ, with resulting hypertension in the portal vein. [More]
Advertisement
Advertisement